Active surveillance provides an important alternative to immediate treatment for early-stage, low-ri Investigators from the phase 3 ARAMIS trial reported a significant delay in PSA progression in ...

Medically reviewed by Matthew Wosnitzer, MD Key Takeaways Most prostate cancers become castration-resistant in about two to ...

Accuracy of a simplified sequencing and bioinformatics platform on genetic variant detection in patients with prostate cancer.